Litcius/Paper detail

PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity

Ruoxin Du, Xiangmei Zhang, Xiyan Lu, Xiangmin Ma, Xinyan Guo, Chao Shi, Xiaofei Ren, Xindi Ma, Yutong He, Yuan Gao, Yunjiang Liu

2023Drug Resistance Updates83 citationsDOI

Topics & Concepts

Antibody-dependent cell-mediated cytotoxicityTrastuzumabCancer researchBreast cancerPodoplaninCancer-Associated FibroblastsImmune systemMedicineCytotoxicityCancer cellCetuximabCancerAntibodyTumor microenvironmentImmunologyMonoclonal antibodyInternal medicineChemistryImmunohistochemistryIn vitroBiochemistryFungal Infections and StudiesT-cell and B-cell ImmunologyLymphoma Diagnosis and Treatment
PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity | Litcius